Birth HIV testing and paediatric treatment programmes

dc.contributor.authorGoga, Ameena Ebrahim
dc.date.accessioned2019-01-28T10:47:33Z
dc.date.issued2018-12
dc.description.abstractIn The Lancet HIV , Karl-Günter Technau and colleagues report on 12-month outcomes of 88 HIV-infected neonates. The infants were identified through birth HIV testing at a well resourced, academic, public maternity hospital in South Africa, an upper-middle-income country with an HIV prevalence of about 32%. Their infant birth HIV testing approach included testing high-risk HIV-exposed infants in era 1 (September, 2013 to May, 2014), testing all HIV-exposed infants in era 2 (June, 2014 to September, 2014), and testing all HIV-exposed infants with added point-of-care (POC) diagnostic PCR testing in era 3 (October, 2014 to June, 2016). The main outcomes were time to antiretroviral therapy (ART) initiation, mortality, retention in care, and viral suppression. Although data are from a single academic site, they provide insight into the effect of early infant HIV testing and ART initiation, which might be generalisable to similar settings. The findings are both encouraging and sobering, raising additional questions on how to optimise WHO's survive, thrive, and transform agenda for HIV-exposed children.en_ZA
dc.description.departmentPaediatrics and Child Healthen_ZA
dc.description.embargo2019-12-01
dc.description.librarianhj2019en_ZA
dc.description.urihttps://www.thelancet.com/journals/lanhiv/issue/currenten_ZA
dc.identifier.citationGoga, A. 2018, 'Birth HIV testing and paediatric treatment programmes', Lancet HIV, vol. 5, no. 12, pp. e675-e676.en_ZA
dc.identifier.issn2405-4704 (print)
dc.identifier.issn2352-3018 (online)
dc.identifier.other10.1016/S2352-3018(18)30291-1
dc.identifier.urihttp://hdl.handle.net/2263/68282
dc.language.isoenen_ZA
dc.publisherElsevieren_ZA
dc.rights© 2018 Elsevier Ltd. All rights reserved. Notice : this is the author’s version of a work that was accepted for publication in Lancet HIV. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in Lancet HIV, vol. 5, no. 12, pp. e675-e676, 2018. doi : 10.1016/S2352-3018(18)30291-1.en_ZA
dc.subjectBirth HIV testingen_ZA
dc.subjectPaediatric treatment programmesen_ZA
dc.subjectHuman immunodeficiency virus (HIV)en_ZA
dc.subjectSouth Africa (SA)en_ZA
dc.titleBirth HIV testing and paediatric treatment programmesen_ZA
dc.typePostprint Articleen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Goga_Birth_2018.pdf
Size:
160.01 KB
Format:
Adobe Portable Document Format
Description:
Postprint Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: